Mereo BioPharma Group plc – Filings and Transcripts

NASDAQ: MREO
Share price (11/6/26): $0.28
Market cap (11/6/26): $45.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Bank of America Corporation

EcoR1 Capital, LLC

EcoR1 Capital, LLC

Bank of America Corporation

News Filter

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights

Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for Alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease

Shareholder Vote Results, Financial Statements or Exhibits

Reports First Quarter 2026 Financial Results and Provides Corporate Highlights

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC